New brain-penetrating RIPK2 inhibitor prodrug for GBM

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer

Cell culture and mouse studies identified a brain-penetrating naphthoquinone-based prodrug of a RIPK2 inhibitor that could help treat

Read the full 226 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE